Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Rocca, B, Buck, G, Petrucci, G, Parish, S, Pagliaccia, F, Baigent, C, Mafham, M, Bowman, L, Armitage, J, Patrono, C
مؤلفون آخرون:	The ASCEND Study Collaborative Group
التنسيق:	Conference item
اللغة:	English
منشور في:	Oxford University Press 2020

مواد مشابهة

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
حسب: Petrucci, G, وآخرون
منشور في: (2024)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
حسب: Parish, S, وآخرون
منشور في: (2023)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
حسب: Aung, T, وآخرون
منشور في: (2017)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
حسب: Sarah Parish, وآخرون
منشور في: (2023-03-01)

Measurement of Thromboxane Biosynthesis in Health and Disease
حسب: Carlo Patrono, وآخرون
منشور في: (2019-10-01)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
حسب: Harper, C, وآخرون
منشور في: (2021)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
حسب: Sammons, E, وآخرون
منشور في: (2024)

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
حسب: Parish, S, وآخرون
منشور في: (2022)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
حسب: Harper, C, وآخرون
منشور في: (2021)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
حسب: Sammons, E, وآخرون
منشور في: (2023)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
حسب: Mafham, MM, وآخرون
منشور في: (2019)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
حسب: Sammons, E, وآخرون
منشور في: (2023)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
حسب: Sammons, EL, وآخرون
منشور في: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
حسب: Sammons, EL, وآخرون
منشور في: (2024)

Foetal vascular responses to thromboxane receptor blockade
حسب: B. A. Meyer, وآخرون
منشور في: (1992-01-01)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
حسب: Emily Sammons, وآخرون
منشور في: (2023-10-01)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
حسب: Giovanna Petrucci, وآخرون
منشور في: (2022-12-01)

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
حسب: Bowman, L, وآخرون
منشور في: (2017)

Urinary leukotriene E4 and 11-dehydro-thromboxane B2 excretion in children with bronchial asthma
حسب: Kaori Yoshikawa, وآخرون
منشور في: (2004-01-01)

Thromboxane Modulates Endothelial Permeability
حسب: J. M. Klausner, وآخرون
منشور في: (1994-01-01)

Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT.
حسب: Thomas J Montine, وآخرون
منشور في: (2010-02-01)

Effects of Fatty Acid Metabolites on Adipocytes Britening: Role of Thromboxane A2
حسب: Cécilia Colson, وآخرون
منشور في: (2023-01-01)

Stability of thromboxane in blood samples
حسب: Helgadóttir H, وآخرون
منشور في: (2019-06-01)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
حسب: Emily L. Sammons, وآخرون
منشور في: (2024-11-01)

Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.
حسب: Mafham, M, وآخرون
منشور في: (2011)

Effects of omega−3 fatty acid supplements on arrhythmias
حسب: Parish, S, وآخرون
منشور في: (2020)

What is the association of COVID-19 with heart attacks and strokes?
حسب: Mafham, M, وآخرون
منشور في: (2021)

Investigation of the Excretion of Triamcinolone Acetonide and Its Metabolite
حسب: Dorota Kwiatkowska, وآخرون
منشور في: (2023-02-01)

Selective COX-2 inhibitors: where do we go from here?
حسب: Baigent, C, وآخرون
منشور في: (2008)

Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
حسب: Patrono, C, وآخرون
منشور في: (2017)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
حسب: Patrono, C, وآخرون
منشور في: (2010)

Selective COX-2 inhibitors: where do we go from here?
حسب: Baigent, C, وآخرون
منشور في: (2008)

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
حسب: Baigent, C, وآخرون
منشور في: (2003)

Nonsteroidal anti-inflammatory drugs and the heart.
حسب: Patrono, C, وآخرون
منشور في: (2014)

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
حسب: Patrono, C, وآخرون
منشور في: (2009)

Role of aspirin in primary prevention of cardiovascular disease
حسب: Patrono, C, وآخرون
منشور في: (2019)

ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction
حسب: Kevin T. Trigani, وآخرون
منشور في: (2022-04-01)

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
حسب: Clarke, R, وآخرون
منشور في: (1991)

Physiological Significance of Thromboxane A2 Receptor Dimerization
حسب: Masako Sasaki, وآخرون
منشور في: (2006-01-01)

Thromboxane Mobilizes Insect Blood Cells to Infection Foci
حسب: Miltan Chandra Roy, وآخرون
منشور في: (2021-12-01)